Most Recent

image: Grading on the Curve

Grading on the Curve

By | June 1, 2012

Actin filaments respond to pressure by forming branches at their curviest spots, helping resist the push.

5 Comments

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

image: Cancer Exosomes Promote Metastasis

Cancer Exosomes Promote Metastasis

By | May 29, 2012

Vesicles released by melanoma cells stimulate pro-metastasis behaviors in bone marrow cells.

2 Comments

image: Food's Afterlife

Food's Afterlife

By | May 25, 2012

Meals left to mold develop colors, mycelia, and beads of digested juices, sparking the eye of an artist, and the slight concern of a mycologist.

0 Comments

image: 2012 Bio-Art Winners

2012 Bio-Art Winners

By | May 25, 2012

Check out the 10 images that won FASEB's first annual Bio-Art competition.

0 Comments

image: Lab Bench Beauty

Lab Bench Beauty

By | May 25, 2012

Ten scientist-produced images take top honors in the first annual Bio-Art competition.

0 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

1 Comment

image: DNA Hard Drive

DNA Hard Drive

By | May 23, 2012

Researchers design the first rewritable biological data storage system.

2 Comments

image: Misconduct on the Rise

Misconduct on the Rise

By | May 21, 2012

Retractions of scientific studies due to plagiarism, falsification, and other instances of researchers behaving badly have skyrocketed in the past decade.

8 Comments

image: Live Slow, Die Old

Live Slow, Die Old

By | May 17, 2012

Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.

13 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech